Prognostic Value of Baseline Quantitative PET Metrics for Patients with Unfavourable Early Stage Hodgkin Lymphoma Enrolled in the Standard Arm of the EORTC/Lysa/FIL H10 Trial

被引：1

作者：

Cottereau, Anne Segolene ^{[1
]}

Versari, Annibale ^{[2
]}

Loft, Annika ^{[3
]}

Casasnovas, Rene-Olivier ^{[4
]}

Bellei, Monica ^{[5
]}

Ricci, Romain ^{[6
]}

Bardet, Stephane ^{[7
]}

Castagnoli, Antonio ^{[8
]}

Brice, Pauline ^{[9
]}

Raemaeker, John ^{[10
]}

Itti, Emmanuel ^{[11
]}

Forpied, Catherine ^{[11
]}

Raveloarivahy, Tiana ^{[12
]}

Girinsky, Theodore ^{[13
]}

Van der Borght, Thierry ^{[14
]}

Federico, Massimo ^{[15
]}

Hutchings, Martin ^{[16
]}

Ricardi, Umberto ^{[17
]}

Meignan, Michel ^{[18
]}

Andre, Marc ^{[19
]}

机构：

[1] Hop Henri Mondor, Nucl Med, Creteil, France

[2] Santa Maria Nuova Hosp, Reggio Emilia, Italy

[3] Copenhagen Univ Hosp, Dep Clin Physiol, Nucl Med, Rigshosp, Copenhagen, Denmark

[4] Univ Hosp, Hematol, Dijon, France

[5] Univ Modena & Reggio Emilia, Dept Diagnost & Clin Med & Publ Hlth, Modena, Italy

[6] LYSARC LYSA Hop Henri Mondor, Creteil, France

[7] CLCC Francois Baclesse, Dept Nucl Med, Caen, France

[8] Osped Santo Stefano, Nucl Med Unit, Prato, Italy

[9] Hop St Louis, APHP, Hematol, Paris, France

[10] Radboud Univ Nijmegen, Med Ctr, Hematol, Nijmegen, Netherlands

[11] Grp Hosp Mondor, APHP, Dept Nucl Med, Creteil, France

[12] European Org Res Treatment Canc, Brussels, Belgium

[13] Inst Gustave Roussy, Villejuif, France

[14] Catholic Univ Louvain, Div Nucl Med, Louvain, Belgium

[15] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy

[16] Rigshosp, Dept Hematol, Copenhagen, Denmark

[17] AO Citta Salute Sci, Sez Radioterapia, Dipartimento Oncol, Turin, Italy

[18] Henri Mondor Univ Hosp, Dept Nucl Med, Creteil, France

[19] CHU UCL NAMUR, Dept Hematol, Yvoir, Belgium

来源：

BLOOD | 2016年 / 128卷 / 22期

关键词：

D O I：

10.1182/blood.V128.22.184.184

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

184

引用

页数：5

共 36 条

[21] Prognosis value of quantitative indices derived from initial FDG PET/CT in untreated mantle cell lymphoma patients enrolled in the Lyma trial, a LYSA study. Preliminary results.
Bodet-Milin, Caroline
Bailly, Clement
Meignan, Michel
Berriolo-riedinger, Alina
Devillers, Anne
Hermine, Oliver
Carlier, Thomas
Hatt, Mathieu
Kraeber-Bodere, Franoise
Le Gouill, Steven
JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (03)
[22] PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup
Fornecker, Luc-Matthieu
Lazarovici, Julien
Aurer, Igor
Casasnovas, Rene-Olivier
Gac, Anne-Claire
Bonnet, Christophe
Bouabdallah, Krimo
Perrot, Aurore
Specht, Lena
Touati, Mohamed
Eisenmann, Jean Claude
Borel, Cecile
Stamatoullas, Aspasia
Nicolas-Virelizier, Emmanuelle
Pascal, Laurent
Lugtenburg, Pieternella
Bellei, Monica
Traverse-Glehen, Alexandra
Copie, Christiane
Hutchings, Martin
Versari, Annibale
Meignan, Michel
Federico, Massimo
Andre, Marc
BLOOD, 2017, 130
[23] Interim positron emission tomography in early stage Hodgkin lymphoma: is there evidence for its prognostic and predictive value in patients treated with standard combined modality treatment?
Specht, Lena
LEUKEMIA & LYMPHOMA, 2013, 54 (06) : 1127 - 1128
[24] First Report On the H10 EORTC/GELA/IIL Randomized Intergroup Trial On Early FDG-PET Scan Guided Treatment Adaptation Versus Standard Combined Modality Treatment in Patients with Supra-Diaphragmatic Stage I/H Hodgkin's Lymphoma, for the Groupe d'Etude Des Lymphomes De l'Adulte (GELA), European Organisation for the Research and Treatment of Cancer (EORTC) Lymphoma Group and the Intergruppo Italiano Linfomi (IIL).
Andre, Marc P. E.
Reman, Oumedaly
Federico, Massimo
Brice, Pauline
Brusamolino, Ercole
Girinski, Theodore
Ferme, Christophe
vander Maazen, Richard
Bellei, Monica
Sebban, Catherine
Morschhauser, Franck
Lugtenburg, Elly
Stamatoullas, Aspasia
Baila, Liliana
Fortpied, Catherine
Meignan, Michel
Raemaekers, John M.
BLOOD, 2009, 114 (22) : 44 - 45
[25] High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline
Lichtman, Marshall A.
Reading, Edward M.
HAEMATOLOGICA, 2022, 107 (12) : 2897 - 2904
[26] Prognostic Value of Baseline Metabolic Tumor Volume in Early-Stage Favorable Hodgkin Lymphoma - Data from the Prospective, Multicenter Phase III HD16 Trial
van Heek, Lutz
Stuka, Colin
Mueller, Horst
Kaul, Helen
Mettler, Jasmin
Hitz, Felicitas
Baues, Christian
Fuchs, Michael
Borchmann, Peter
Voltin, Conrad-Amadeus
Engert, Andreas
Dietlein, Markus
Kobe, Carsten
JOURNAL OF NUCLEAR MEDICINE, 2022, 63
[27] Early Reduction of Serum TARC Levels Predicts Prognosis of Patients Treated with a PET-Adapted Strategy for Advanced Stage Hodgkin Lymphoma (HL) in the GITIL/FIL HD0607 Trial
Viviani, Simonetta
Mazzocchi, Arabella
Pavoni, Chiara
Taverna, Francesca
Guidetti, Anna
Rossi, Andrea
Patti, Caterina
Romano, Alessandra
Trentin, Livio
Rapezzi, Davide
Gottardi, Daniela
Tarella, Corrado
Cimminiello, Michele
Zanotti, Roberta
Ferreri, Andres J. M.
Serpi, Roberta
Corradini, Paolo
Gianni, Alessandro M.
Gallamini, Andrea
Rambaldi, Alessandro
BLOOD, 2017, 130
[28] Prognostic value of baseline tumor burden and tumor dissemination extracted from 18F-FDG PET/CT in a cohort of adult patients with early and advanced Hodgkin lymphoma
Mouheb, Mehdi
Pierre-Jean, Morgane
Devillers, Anne
Ferme, Christophe
Benchalal, Mohamed
Manson, Guillaume
Le Jeune, Florence
Houot, Roch
Palard-Novello, Xavier
JOURNAL OF NUCLEAR MEDICINE, 2023, 64
[29] Prognostic Value of Baseline Tumor Burden and Tumor Dissemination Extracted From 18F-FDG PET/CT in a Cohort of Adult Patients With Early or Advanced Hodgkin Lymphoma
Mouheb, Mehdi
Pierre-Jean, Morgane
Devillers, Anne
Ferme, Christophe
Benchalal, Mohamed
Manson, Guillaume
Le Jeune, Florence
Houot, Roch
Palard-Novello, Xavier
CLINICAL NUCLEAR MEDICINE, 2024, 49 (01) : E1 - E5
[30] Prognostic value of baseline metabolic tumor volume (MTV) for forecasting chemotherapy outcome in early-stage unfavorable Hodgkin lymphoma: Data from the phase III HD17 trial
van Heek, Lutz
Weindler, Jasmin
Gorniak, Claudia
Kaul, Helen
Mueller, Horst
Mettler, Jasmin
Baues, Christian
Fuchs, Michael
Borchmann, Peter
Ferdinandus, Justin
Dietlein, Markus
Voltin, Conrad-Amadeus
Kobe, Carsten
Roth, Katrin S.
EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 111 (06) : 881 - 887

← 1 2 3 4 →